INTELLIGENCE

Monitoring global regulatory movements, compliance updates, and scientific breakthroughs in peptide research.

LIVE FEED

201 ARTICLES
MONITOR
OCNJ Daily

KLOW vs GLOW Peptide Blends: A Research Comparison

KLOW vs GLOW Peptide Blends: A Research Comparison    OCNJ Daily

Research
REGULATORY
Post and Courier

FDA staff question peptides backed by Kennedy ahead of advisory panel review

FDA staff question peptides backed by Kennedy ahead of advisory panel review    Post and Courier

FDA
MONITOR
TradingView

HIMS Stock Logs Worst Week In 2 Months — Turns To Peptides Campaign Ahead Of Key FDA Meeting

HIMS Stock Logs Worst Week In 2 Months — Turns To Peptides Campaign Ahead Of Key FDA Meeting    TradingView

FDA
MONITOR
Cleveland Clinic Health Essentials

Tirzepatide vs. Semaglutide: What You Should Know

Tirzepatide vs.

SemaglutideTirzepatide
MONITOR
news36live

bpc 157 nfl A new KFF/ @espn survey finds that a variety of health issues affect NFL players from the 1988 season, including chronic pain and mobility problems, cognitive impairment, and mental health challenges –

bpc 157 nfl A new KFF/ @espn survey finds that a variety of health issues affect NFL players from the 1988 season, including chronic pain and mobility problems, cognitive impairment, and mental health challenges –    news36live

BPC-157
MONITOR
news36live

bpc 157 legality california 🙋🏻‍♂️ Is the lack of human data in BPC-157 a red flag? • If a drug could actually knit torn tendons back together in weeks, a trillion-dollar pharmaceutical industry probably wouldn't bury

bpc 157 legality california 🙋🏻‍♂️ Is the lack of human data in BPC-157 a red flag?

BPC-157
MONITOR
Marie Claire UK

Meet GHK-Cu, the Copper Peptide Taking Over Your Skincare Feed—Here's Whether It's Worth the Hype

Meet GHK-Cu, the Copper Peptide Taking Over Your Skincare Feed—Here's Whether It's Worth the Hype    Marie Claire UK

GHK-CU
REGULATORY
Neurology Advisor

FDA Scientists Warn Against Expanded Peptide Access as Kennedy Reshapes Advisory Panel

FDA Scientists Warn Against Expanded Peptide Access as Kennedy Reshapes Advisory Panel    Neurology Advisor

FDA
MONITOR
Drug Topics

FDA Panel to Evaluate 7 Popular Peptides for Compounding Substances List

FDA Panel to Evaluate 7 Popular Peptides for Compounding Substances List    Drug Topics

FDA
REGULATORY
Barron's

Trump’s FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Trump’s FDA May Soon Throw Its Weight Behind Peptides.

FDA
REGULATORY
Reuters

FDA staff question peptides backed by Kennedy ahead of advisory panel review

FDA staff question peptides backed by Kennedy ahead of advisory panel review    Reuters

FDA
MONITOR
MedPage Today

FDA Scientists Raise Peptide Concerns Ahead of Committee Meeting

FDA Scientists Raise Peptide Concerns Ahead of Committee Meeting    MedPage Today

FDA
REGULATORY
U.S. News & World Report

FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel

FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel    U.

MT-IFDA
MONITOR
News-Medical

Study links semaglutide and tirzepatide to fewer anxiety and depression diagnoses in obesity care

Study links semaglutide and tirzepatide to fewer anxiety and depression diagnoses in obesity care    News-Medical

SemaglutideTirzepatideObesity
MONITOR
Woman's World

What Is Retatrutide? Dr. Dubrow Calls It the Most Powerful Weight-Loss Drug

What Is Retatrutide?

Retatrutide
REGULATORY
Iowa Public Radio

FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports

FDA scientists flag concerns with peptides, the trendy molecules RFK Jr.

FDA
REGULATORY
The Business of Fashion

FDA Staff Question Peptides Backed by Kennedy Ahead of Review

FDA Staff Question Peptides Backed by Kennedy Ahead of Review    The Business of Fashion

FDA
REGULATORY
NPR

FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports

FDA scientists flag concerns with peptides, the trendy molecules RFK Jr.

FDA
REGULATORY
NBC News

RFK Jr. wants to make it easier to get peptides. FDA scientists disagree.

FDA scientists disagree.

FDA
REGULATORY
Yahoo Finance

FDA Sets Peptide Impurity Thresholds as Low as 0.10%, Oath Research Analysis Finds

FDA Sets Peptide Impurity Thresholds as Low as 0.

FDAResearch
REGULATORY
WBUR

FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports

FDA scientists flag concerns with peptides, the trendy molecules RFK Jr.

FDA
REGULATORY
Politico

FDA unveils peptides position

FDA unveils peptides position    Politico

FDA
REGULATORY
Yahoo

US FDA staff highlights peptide risks, says little evidence of benefits

US FDA staff highlights peptide risks, says little evidence of benefits    Yahoo

FDA
REGULATORY
PBS

FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.

FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.

FDA
REGULATORY
MedPage Today

FDA Panel on Peptides Will Include Experts Who Promote the Unproven Chemicals

FDA Panel on Peptides Will Include Experts Who Promote the Unproven Chemicals    MedPage Today

FDA
REGULATORY
STAT

Longevity, wellness physicians named to panel advising FDA on peptides

Longevity, wellness physicians named to panel advising FDA on peptides    STAT

FDA
MONITOR
The Guardian

FDA to discuss easing restrictions on peptides despite safety concerns

FDA to discuss easing restrictions on peptides despite safety concerns    The Guardian

FDA
REGULATORY
Hone Health

Survey: Half of Peptide-Users Aren’t Aware of FDA Approval Status

Survey: Half of Peptide-Users Aren’t Aware of FDA Approval Status    Hone Health

FDA
MONITOR
Cureus

Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review

Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review    Cureus

TirzepatideMT-II
MONITOR
GlobeNewswire

The Key to Healthy Aging: NMN Supplements Shown to Boost NAD+ Levels

The Key to Healthy Aging: NMN Supplements Shown to Boost NAD+ Levels    GlobeNewswire

NAD+
REGULATORY
PR Newswire

Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity

Ascletis Announces U.

FDAObesity
MONITOR
Docwire News

TRIUMPH-1 Trial Shows Potential for Retatrutide As a Treatment for Obesity

TRIUMPH-1 Trial Shows Potential for Retatrutide As a Treatment for Obesity    Docwire News

RetatrutideObesity
REGULATORY
Bloomberg.com

Watch FDA to Review Easing Restrictions on Peptides

Watch FDA to Review Easing Restrictions on Peptides    Bloomberg.

HCGFDA
MONITOR
Medical News Today

How GLP-1 drug semaglutide may play a role in reproductive health

How GLP-1 drug semaglutide may play a role in reproductive health    Medical News Today

Semaglutide
REGULATORY
Reason Magazine

How the FDA Created a Peptide Black Market

How the FDA Created a Peptide Black Market    Reason Magazine

FDA
MONITOR
Charlotte Observer

Peptide Interest Is Growing Fast, but the FDA's Actual 2026 Docket Is Far Smaller Than Reported

Peptide Interest Is Growing Fast, but the FDA's Actual 2026 Docket Is Far Smaller Than Reported    Charlotte Observer

FDA
MONITOR
Raleigh News & Observer

Doctors Weigh In on Where the NAD+ IV Trend Is Headed, What's in the Bag and Whether It's Worth It

Doctors Weigh In on Where the NAD+ IV Trend Is Headed, What's in the Bag and Whether It's Worth It    Raleigh News & Observer

NAD+
REGULATORY
Public Citizen

The ‘Miracle Drug’ and the Peptide Craze Breaking the FDA

The ‘Miracle Drug’ and the Peptide Craze Breaking the FDA    Public Citizen

FDA
MONITOR
The New York Times

Glutathione Is Vital for Health. Is It Worth Buying as a Supplement?

Glutathione Is Vital for Health.

Glutathione
MONITOR
The American Journal of Managed Care® (AJMC®)

ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity

ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity    The American Journal of Managed Care® (AJMC®)

SemaglutideTirzepatideObesity
MONITOR
Medical News Today

Type 2 diabetes: Semaglutide may help protect bone health

Type 2 diabetes: Semaglutide may help protect bone health    Medical News Today

Semaglutide
MONITOR
MedPage Today

Diabetes Patients on Semaglutide Had Fewer Fractures, Study Finds

Diabetes Patients on Semaglutide Had Fewer Fractures, Study Finds    MedPage Today

Semaglutide
MONITOR
Medical Xpress

ADA: Once-weekly cagrilintide + semaglutide promising in type 2 diabetes

ADA: Once-weekly cagrilintide + semaglutide promising in type 2 diabetes    Medical Xpress

SemaglutideCagrilintideCagrilintide + Semaglutide
MONITOR
Medscape

Semaglutide Tablet Wins UK Approval for Weight Loss

Semaglutide Tablet Wins UK Approval for Weight Loss    Medscape

SemaglutideWeight Loss
MONITOR
Cureus

Acute Small Bowel Obstruction Induced by Tirzepatide (Mounjaro)

Acute Small Bowel Obstruction Induced by Tirzepatide (Mounjaro)    Cureus

Tirzepatide
MONITOR
Motley Rice

Tirzepatide Deaths

Tirzepatide Deaths    Motley Rice

Tirzepatide
MONITOR
Everyday Health

Is Retatrutide Too Strong? What Doctors Who Prescribe Weight Loss Drugs Want You to Know

Is Retatrutide Too Strong?

RetatrutideWeight Loss
MONITOR
Medscape

No Increased Retinopathy Risk Seen With Tirzepatide

No Increased Retinopathy Risk Seen With Tirzepatide    Medscape

Tirzepatide
REGULATORY
Drug Topics

Alabama Board of Medical Examiners Issues Warning of Non-FDA-Approved Peptides

Alabama Board of Medical Examiners Issues Warning of Non-FDA-Approved Peptides    Drug Topics

FDA
MONITOR
The American Journal of Managed Care® (AJMC®)

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes    The American Journal of Managed Care® (AJMC®)

SemaglutideWeight Loss
MONITOR
Forbes

Tirzepatide vs Semaglutide For Weight Loss: What’s The Difference?

Tirzepatide vs Semaglutide For Weight Loss: What’s The Difference?

SemaglutideTirzepatideWeight Loss
MONITOR
Forbes

Retatrutide vs. Semaglutide for Weight Loss—What’s the Difference?

Retatrutide vs.

SemaglutideRetatrutideWeight Loss
MONITOR
Docwire News

Tackling Psoriasis and Overweight/Obesity Together

Tackling Psoriasis and Overweight/Obesity Together    Docwire News

Obesity
REGULATORY
Pulitzer Center

Stress Test: The Hidden History of a Peptide in FDA's Sights

Stress Test: The Hidden History of a Peptide in FDA's Sights    Pulitzer Center

FDA
MONITOR
Business Wire

Mountain Valley MD Advances Quicksome™ Sublingual Delivery Platform for Compounded Peptide Applications, Reports on Initial Formulation Work Across Multiple Peptides Including BPC-157

Mountain Valley MD Advances Quicksome™ Sublingual Delivery Platform for Compounded Peptide Applications, Reports on Initial Formulation Work Across Multiple Peptides Including BPC-157    Business Wire

BPC-157KPV (Lysine–Proline–Valine)
MONITOR
Wiley Online Library

Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta‐Analysis of Randomized Clinical Trials - Hamarsheh - 2026 - Endocrinology, Diabetes & Metabolism

Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta‐Analysis of Randomized Clinical Trials - Hamarsheh - 2026 - Endocrinology, Diabetes & Metabolism    Wiley Online Library

SemaglutideTirzepatideCagrilintideClinical Trial
MONITOR
ScienceAlert

One Weight Loss Strategy Is 5x More Effective Than Ozempic, Study Shows

One Weight Loss Strategy Is 5x More Effective Than Ozempic, Study Shows    ScienceAlert

Weight Loss
REGULATORY
Reuters

Alabama warns healthcare providers against use of non-FDA-approved peptides

Alabama warns healthcare providers against use of non-FDA-approved peptides    Reuters

FDA
REGULATORY
Spectrum News

Health experts warn against injecting peptides that aren't FDA approved

Health experts warn against injecting peptides that aren't FDA approved    Spectrum News

FDA
REGULATORY
WBRC

Officials shed light on non-FDA approved peptide warning

Officials shed light on non-FDA approved peptide warning    WBRC

FDA
REGULATORY
WSFA

Warnings issued to Alabama doctors against non-FDA-approved peptides amid social media popularity

Warnings issued to Alabama doctors against non-FDA-approved peptides amid social media popularity    WSFA

MT-IFDA
MONITOR
Conexiant

Semaglutide Reduced Nicotine Craving in Small Trial

Semaglutide Reduced Nicotine Craving in Small Trial    Conexiant

Semaglutide
MONITOR
UCL | University College London

Weight loss drug semaglutide helps patients who do not respond to bariatric surgery

Weight loss drug semaglutide helps patients who do not respond to bariatric surgery    UCL | University College London

SemaglutideWeight Loss
MONITOR
MobiHealthNews

Hims & Hers launches generic semaglutide offering in Canada

Hims & Hers launches generic semaglutide offering in Canada    MobiHealthNews

Semaglutide
REGULATORY
Fox News

‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access

‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access    Fox News

FDA
MONITOR
Everyday Health

Retatrutide Helped Adults With Obesity Lose Up to 30 Percent of Their Body Weight in New Trial

Retatrutide Helped Adults With Obesity Lose Up to 30 Percent of Their Body Weight in New Trial    Everyday Health

RetatrutideMT-IObesity
MONITOR
LiveNOW from FOX

Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial

Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial    LiveNOW from FOX

RetatrutideClinical TrialObesityWeight Loss
MONITOR
FOX 10 Phoenix

Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial

Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial    FOX 10 Phoenix

RetatrutideClinical TrialObesityWeight Loss
MONITOR
MedCity News

Eli Lilly’s Triple Combo Obesity Drug Tops 28% Weight Loss in a Pivotal Trial

Eli Lilly’s Triple Combo Obesity Drug Tops 28% Weight Loss in a Pivotal Trial    MedCity News

ObesityWeight Loss
REGULATORY
Forbes

The FDA Could Ease Restrictions On Peptides This Summer—What Consumers Should Know

The FDA Could Ease Restrictions On Peptides This Summer—What Consumers Should Know    Forbes

FDA
MONITOR
EMJ

Ixekizumab and Tirzepatide Deliver Dual Benefits in Psoriasis Trial

Ixekizumab and Tirzepatide Deliver Dual Benefits in Psoriasis Trial    EMJ

Tirzepatide
MONITOR
The Conversation

Can supplements containing NMN, NAD+ and resveratrol really slow ageing? Here’s what the evidence says

Can supplements containing NMN, NAD+ and resveratrol really slow ageing?

NAD+
REGULATORY
Mintz

FDA in Flux — May 2026 Newsletter

FDA in Flux — May 2026 Newsletter    Mintz

FDA
MONITOR
Newswise

Early Use of Tirzepatide Better Improves Blood Sugar Control Compared with Standard Care in Type 2 Diabetes | Newswise

Early Use of Tirzepatide Better Improves Blood Sugar Control Compared with Standard Care in Type 2 Diabetes | Newswise    Newswise

Tirzepatide
MONITOR
EMJ

Orforglipron Pill Sustains Weight Loss After Injection Discontinuation

Orforglipron Pill Sustains Weight Loss After Injection Discontinuation    EMJ

Weight Loss
REGULATORY
Drug Topics

FDA Proposes to Exclude GLP-1s From 503B Bulk List

FDA Proposes to Exclude GLP-1s From 503B Bulk List    Drug Topics

KPV (Lysine–Proline–Valine)FDA
MONITOR
News-Medical

Once-daily orforglipron helps preserve weight loss after semaglutide or tirzepatide

Once-daily orforglipron helps preserve weight loss after semaglutide or tirzepatide    News-Medical

SemaglutideTirzepatideWeight Loss
MONITOR
Healio

Adults switching from injectable drug to Foundayo maintain majority of weight loss

Adults switching from injectable drug to Foundayo maintain majority of weight loss    Healio

Weight Loss
MONITOR
News-Medical

Semaglutide significantly reduces obesity in treatment-resistant young adults

Semaglutide significantly reduces obesity in treatment-resistant young adults    News-Medical

SemaglutideObesity
REGULATORY
Allure

The FDA May Reverse a Ban on Several Peptides With Potential Beauty Benefits. What Does That Mean, Exactly?

The FDA May Reverse a Ban on Several Peptides With Potential Beauty Benefits.

FDA
MONITOR
Conexiant

Semaglutide Linked to NAION Risk

Semaglutide Linked to NAION Risk    Conexiant

Semaglutide
MONITOR
EMJ

Semaglutide Cuts Heavy Drinking in Alcohol Use Disorder Trial

Semaglutide Cuts Heavy Drinking in Alcohol Use Disorder Trial    EMJ

Semaglutide
REGULATORY
Foley & Lardner LLP

FDA to Consider Lifting Restrictions on Numerous Compounded Peptides

FDA to Consider Lifting Restrictions on Numerous Compounded Peptides    Foley & Lardner LLP

FDA
REGULATORY
Fox News

Peptides gain popularity for wellness amid FDA scrutiny

Peptides gain popularity for wellness amid FDA scrutiny    Fox News

FDA
MONITOR
Medscape

Tirzepatide Tied to Less Mortality and AEs Than Semaglutide

Tirzepatide Tied to Less Mortality and AEs Than Semaglutide    Medscape

SemaglutideTirzepatideHCG
MONITOR
JD Supra

FDA Moves to Shut the Door on Large-Scale Compounding of GLP-1 Drugs

FDA Moves to Shut the Door on Large-Scale Compounding of GLP-1 Drugs    JD Supra

FDA
REGULATORY
sciencenews.org

Peptides are unproven as health aids. FDA may unleash them anyway

FDA may unleash them anyway    sciencenews.

FDA
MONITOR
The Clinical Trial Vanguard

Semaglutide Just Passed Its Hardest Test Yet — And the FDA Has No Roadmap for What Comes Next

Semaglutide Just Passed Its Hardest Test Yet — And the FDA Has No Roadmap for What Comes Next    The Clinical Trial Vanguard

SemaglutideFDAClinical Trial
MONITOR
Renal and Urology News

High-Dose Tirzepatide Linked to Greater HbA1c, Weight Loss vs Semaglutide

High-Dose Tirzepatide Linked to Greater HbA1c, Weight Loss vs Semaglutide    Renal and Urology News

SemaglutideTirzepatideWeight Loss
REGULATORY
JD Supra

The Peptide Boom Meets FDA Reality

The Peptide Boom Meets FDA Reality    JD Supra

FDA
REGULATORY
STAT

Did Kennedy just stack the deck on FDA oversight of peptides?

Did Kennedy just stack the deck on FDA oversight of peptides?

FDA
MONITOR
Renal and Urology News

Synthetic Semaglutide vs Ozempic: Comparable Efficacy in Type 2 Diabetes

Synthetic Semaglutide vs Ozempic: Comparable Efficacy in Type 2 Diabetes    Renal and Urology News

Semaglutide
REGULATORY
Drug Topics

FDA Set to Review Peptide Access for Compounding Pharmacies

FDA Set to Review Peptide Access for Compounding Pharmacies    Drug Topics

FDA
REGULATORY
inc.com

From Looksmaxxing to FDA Approval? The U.S. Considers Greenlighting Mystery Peptides

From Looksmaxxing to FDA Approval?

FDA
MONITOR
EurekAlert!

GLP-1–based drug tirzepatide reduces heart risk in high-risk patients

GLP-1–based drug tirzepatide reduces heart risk in high-risk patients    EurekAlert!

Tirzepatide
REGULATORY
NBC News

The FDA considers easing limits on peptides use

The FDA considers easing limits on peptides use    NBC News

FDA
MONITOR
News-Medical

Tirzepatide vs. semaglutide: Study compares cost and health outcomes in obesity

Tirzepatide vs.

SemaglutideTirzepatideObesity
REGULATORY
NBC News

What are peptides and why is the FDA considering easing limits?

What are peptides and why is the FDA considering easing limits?

FDA
REGULATORY
Bloomberg.com

Are Peptides Just Snake Oil? Don’t Ask the FDA

Don’t Ask the FDA    Bloomberg.

FDA
REGULATORY
Medical Professionals Reference

FDA To Review Whether To Allow More Access To Certain Peptides

FDA To Review Whether To Allow More Access To Certain Peptides    Medical Professionals Reference

FDA
MONITOR
Health: Trusted and Empathetic Health and Wellness Information

Why You Might Tolerate One Weight Loss Drug Better Than Another, According to Experts

Why You Might Tolerate One Weight Loss Drug Better Than Another, According to Experts    Health: Trusted and Empathetic Health and Wellness Information

Weight Loss
MONITOR
Health: Trusted and Empathetic Health and Wellness Information

7 Medications and Supplements Not To Mix With NAD+

7 Medications and Supplements Not To Mix With NAD+    Health: Trusted and Empathetic Health and Wellness Information

NAD+
REGULATORY
The Dermatology Digest

Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides

Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides    The Dermatology Digest

FDA
REGULATORY
JD Supra

FDA Announces Removal of 12 Peptides from Category 2 and Schedules PCAC Meetings to Consider Adding Peptides to 503A Bulk Drug Substances List

FDA Announces Removal of 12 Peptides from Category 2 and Schedules PCAC Meetings to Consider Adding Peptides to 503A Bulk Drug Substances List    JD Supra

FDA
REGULATORY
Yahoo Finance

Hims & Hers stock rises 14% as FDA schedules peptide compounding review

Hims & Hers stock rises 14% as FDA schedules peptide compounding review    Yahoo Finance

FDA
REGULATORY
BioPharma Dive

FDA moves toward easing restrictions on certain peptides

FDA moves toward easing restrictions on certain peptides    BioPharma Dive

FDA
MONITOR
RAPS

FDA considers adding a dozen peptides to its bulk drug compounding list

FDA considers adding a dozen peptides to its bulk drug compounding list    RAPS

FDA
REGULATORY
The American Journal of Managed Care® (AJMC®)

FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate

FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate    The American Journal of Managed Care® (AJMC®)

FDA
REGULATORY
Yahoo Finance

Hims & Hers stock extends gains as RFK Jr. signals FDA will consider looser restrictions on peptides

Hims & Hers stock extends gains as RFK Jr.

FDA
REGULATORY
Reuters

Hims rises as FDA considers broader peptides access; analysts see long-term win

Hims rises as FDA considers broader peptides access; analysts see long-term win    Reuters

FDA
MONITOR
BioSpace

FDA mulls compounding for peptides previously flagged over safety risks

FDA mulls compounding for peptides previously flagged over safety risks    BioSpace

FDA
REGULATORY
Ars Technica

RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban

RFK Jr.

FDA
REGULATORY
Buchanan Ingersoll & Rooney PC

What FDA’s Latest Peptide Action Really Means for Compounding Pharmacies

What FDA’s Latest Peptide Action Really Means for Compounding Pharmacies    Buchanan Ingersoll & Rooney PC

FDA
REGULATORY
Yahoo Finance

Hims stock gains as FDA reviews peptides, Voyager secures NASA contract

Hims stock gains as FDA reviews peptides, Voyager secures NASA contract    Yahoo Finance

FDA
MONITOR
The Conversation

Will retatrutide help me lose weight or look ‘shredded’?

Will retatrutide help me lose weight or look ‘shredded’?

Retatrutide
REGULATORY
Reuters

US FDA to convene expert panel to review wider access to some peptides

US FDA to convene expert panel to review wider access to some peptides    Reuters

FDA
REGULATORY
AP News

FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures

FDA to weigh easing limits on unproven peptides favored by RFK Jr.

FDA
REGULATORY
Fierce Pharma

UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting

UPDATED: Heeding RFK Jr.

FDA
REGULATORY
STAT

FDA panel will meet to discuss allowing broader access to certain peptides

FDA panel will meet to discuss allowing broader access to certain peptides    STAT

FDA
REGULATORY
The Washington Post

Amid wellness craze, FDA weighs lifting peptide restrictions

Amid wellness craze, FDA weighs lifting peptide restrictions    The Washington Post

FDA
MONITOR
Ro

Retatrutide vs. Tirzepatide: Which Is Better for Weight Control?

Retatrutide vs.

TirzepatideRetatrutide
REGULATORY
Six Minute Mile

The FDA may soon lift its ban on injectable peptides

The FDA may soon lift its ban on injectable peptides    Six Minute Mile

FDA
MONITOR
Nature

Early intervention with tirzepatide or semaglutide influences anti-atherosclerotic effects in ApoE knockout mice

Early intervention with tirzepatide or semaglutide influences anti-atherosclerotic effects in ApoE knockout mice    Nature

SemaglutideTirzepatide
REGULATORY
ProPublica

RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work.

” Former FDA Officials Say He Mischaracterized Their Work.

FDA
MONITOR
Dove Medical Press

Real-World Effectiveness and Safety of Tirzepatide, Semaglutide, and L | DMSO

Real-World Effectiveness and Safety of Tirzepatide, Semaglutide, and L | DMSO    Dove Medical Press

SemaglutideTirzepatide
MONITOR
MEXC

How Do SS-31 and Klow Peptide Compare for Tissue Regeneration?

How Do SS-31 and Klow Peptide Compare for Tissue Regeneration?

SS-31
REGULATORY
PBS

Makers of dietary supplements push the FDA to allow peptides and other new ingredients

Makers of dietary supplements push the FDA to allow peptides and other new ingredients    PBS

FDA
MONITOR
Cleveland Clinic Newsroom

Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease

Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease    Cleveland Clinic Newsroom

Tirzepatide
MONITOR
Healio

Tirzepatide tied to lower cardiovascular risk than dulaglutide in type 2 diabetes

Tirzepatide tied to lower cardiovascular risk than dulaglutide in type 2 diabetes    Healio

Tirzepatide
MONITOR
Science Media Centre España

Oral semaglutide does not slow the progression of Alzheimer's disease, according to a trial

Oral semaglutide does not slow the progression of Alzheimer's disease, according to a trial    Science Media Centre España

Semaglutide
MONITOR
ScienceDaily

What happens after Ozempic shocked researchers

What happens after Ozempic shocked researchers    ScienceDaily

Research
MONITOR
Science Media Centre España

A study in mice and human tissue shows that the antioxidant glutathione feeds cancer cells

A study in mice and human tissue shows that the antioxidant glutathione feeds cancer cells    Science Media Centre España

Glutathione
MONITOR
Cleveland Clinic

Cost, Side Effects Top Reasons for Quitting GLP-1s for Obesity

Cost, Side Effects Top Reasons for Quitting GLP-1s for Obesity    Cleveland Clinic

Obesity
REGULATORY
KevinMD.com

Why the FDA regulations on peptide therapy matter

Why the FDA regulations on peptide therapy matter    KevinMD.

FDA
REGULATORY
MedPage Today

RFK Jr. Says FDA Will Lift Ban on Peptides

RFK Jr.

FDA
MONITOR
Nature

Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial

Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial    Nature

SemaglutideObesity
MONITOR
Cleveland Clinic Health Essentials

NAD+ Supplements: Can They Really Slow Down Aging?

NAD+ Supplements: Can They Really Slow Down Aging?

NAD+
MONITOR
The American Journal of Managed Care® (AJMC®)

Oral Semaglutide Reduces Heart Failure Events in Type 2 Diabetes

Oral Semaglutide Reduces Heart Failure Events in Type 2 Diabetes    The American Journal of Managed Care® (AJMC®)

Semaglutide
MONITOR
Nature

The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs

The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs    Nature

Semaglutide
MONITOR
Ophthalmology Advisor

Tirzepatide May Lower Glaucoma Risk Among Patients With Type 2 Diabetes

Tirzepatide May Lower Glaucoma Risk Among Patients With Type 2 Diabetes    Ophthalmology Advisor

Tirzepatide
MONITOR
Nature

Fecal microbiome predicts treatment response after the initiation of semaglutide or empagliflozin uptake

Fecal microbiome predicts treatment response after the initiation of semaglutide or empagliflozin uptake    Nature

Semaglutide
MONITOR
Mayo Clinic News Network

New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause

New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause    Mayo Clinic News Network

TirzepatideWeight Loss
MONITOR
Healio

Tirzepatide may improve ASCVD risk in those who achieve lower BMI

Tirzepatide may improve ASCVD risk in those who achieve lower BMI    Healio

Tirzepatide
MONITOR
ScienceDaily

This weight loss option beats Ozempic by 5 times

This weight loss option beats Ozempic by 5 times    ScienceDaily

Weight Loss
MONITOR
Docwire News

Tirzepatide in SURPASS‑CVOT: Favorable Cardiovascular Outcomes in Type 2 Diabetes

Tirzepatide in SURPASS‑CVOT: Favorable Cardiovascular Outcomes in Type 2 Diabetes    Docwire News

Tirzepatide
MONITOR
CNBC

Novo Nordisk's 'long game' on weight loss drugs sparks hope in science, but the Street is impatient

Novo Nordisk's 'long game' on weight loss drugs sparks hope in science, but the Street is impatient    CNBC

Weight Loss
MONITOR
HCP Live

Orforglipron Maintains Weight Loss in Patients Switching from Semaglutide or Tirzepatide

Orforglipron Maintains Weight Loss in Patients Switching from Semaglutide or Tirzepatide    HCP Live

SemaglutideTirzepatideWeight Loss
MONITOR
Nature

Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes

Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes    Nature

Mazdutide
MONITOR
Psychiatric Times

Semaglutide Potentially Protective Against Nephrotoxicity Caused by Lithium

Semaglutide Potentially Protective Against Nephrotoxicity Caused by Lithium    Psychiatric Times

Semaglutide
MONITOR
Neurology Advisor

Oral Semaglutide Fails in Early Alzheimer Disease Trials

Oral Semaglutide Fails in Early Alzheimer Disease Trials    Neurology Advisor

Semaglutide
MONITOR
Nature

Alpha-actinin-1, profilin-1, filamin-A, integrin alpha-M and glutathione synthase were identified to be associated with cognitive and social functions of schizophrenia

Alpha-actinin-1, profilin-1, filamin-A, integrin alpha-M and glutathione synthase were identified to be associated with cognitive and social functions of schizophrenia    Nature

MT-IIGlutathione
MONITOR
Docwire News

Semaglutide Falls Short in Slowing Alzheimer’s Disease Progression

Semaglutide Falls Short in Slowing Alzheimer’s Disease Progression    Docwire News

Semaglutide
MONITOR
ScienceDaily

New evidence shows tirzepatide and semaglutide strongly protect the heart

New evidence shows tirzepatide and semaglutide strongly protect the heart    ScienceDaily

SemaglutideTirzepatide
MONITOR
Cureus

Association Between Semaglutide or Tirzepatide Therapy and Residual Gastric Content: A Potential Danger During Upper Endoscopy

Association Between Semaglutide or Tirzepatide Therapy and Residual Gastric Content: A Potential Danger During Upper Endoscopy    Cureus

SemaglutideTirzepatide
MONITOR
Nature

Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice

Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice    Nature

SemaglutideTirzepatide
MONITOR
Consultant360

Does Semaglutide Use Increase the Risk of Urinary Stone Disease?

Does Semaglutide Use Increase the Risk of Urinary Stone Disease?

Semaglutide
MONITOR
Endocrinology Advisor

Kidney, CV Outcomes Similar Between Liraglutide, Semaglutide, Dulaglutide in T2D

Kidney, CV Outcomes Similar Between Liraglutide, Semaglutide, Dulaglutide in T2D    Endocrinology Advisor

Semaglutide
MONITOR
Cleveland Clinic

Tirzepatide Linked to Better Heart Outcomes Than Semaglutide in MASLD, Obesity and Diabetes

Tirzepatide Linked to Better Heart Outcomes Than Semaglutide in MASLD, Obesity and Diabetes    Cleveland Clinic

SemaglutideTirzepatideObesity
MONITOR
Northwestern University

Obesity Drugs Regulate Neural Systems to Curb Appetite

Obesity Drugs Regulate Neural Systems to Curb Appetite    Northwestern University

Obesity
MONITOR
Psychiatric Times

Study Finds Semaglutide Is Associated With Improved Cognitive Function in Individuals With Psychiatric Disorders

Study Finds Semaglutide Is Associated With Improved Cognitive Function in Individuals With Psychiatric Disorders    Psychiatric Times

Semaglutide
MONITOR
Renal and Urology News

Semaglutide, Tirzepatide Lower HF Hospitalizations, Death Risks in HFpEF, T2D

Semaglutide, Tirzepatide Lower HF Hospitalizations, Death Risks in HFpEF, T2D    Renal and Urology News

SemaglutideTirzepatide
MONITOR
Cardiovascular Business

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes    Cardiovascular Business

SemaglutideFDA
MONITOR
Medscape

Semaglutide, Tirzepatide Named First-Line Drugs for Obesity

Semaglutide, Tirzepatide Named First-Line Drugs for Obesity    Medscape

SemaglutideTirzepatideObesity
MONITOR
Docwire News

Tirzepatide and Semaglutide Most Efficacious for Weight Loss and Complication Remission in Obesity

Tirzepatide and Semaglutide Most Efficacious for Weight Loss and Complication Remission in Obesity    Docwire News

SemaglutideTirzepatideObesityWeight Loss
MONITOR
Medical Xpress

Semaglutide, tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance

Semaglutide, tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance    Medical Xpress

SemaglutideTirzepatideObesity
MONITOR
MedPage Today

Jenny McCarthy's Glutathione and Tylenol Claims: Medical Toxicologist Weighs In

Jenny McCarthy's Glutathione and Tylenol Claims: Medical Toxicologist Weighs In    MedPage Today

Glutathione
MONITOR
WWD

Newly Appointed Aramore CEO Melisse Shaban Discusses NAD+, Skin Longevity and the Brand’s Next Steps

Newly Appointed Aramore CEO Melisse Shaban Discusses NAD+, Skin Longevity and the Brand’s Next Steps    WWD

NAD+
MONITOR
Medscape

First Randomized Trial of Tirzepatide in T1D Shows Benefits

First Randomized Trial of Tirzepatide in T1D Shows Benefits    Medscape

Tirzepatide
MONITOR
Cardiovascular Business

Oral semaglutide linked to significant weight loss as Novo Nordisk awaits FDA approval

Oral semaglutide linked to significant weight loss as Novo Nordisk awaits FDA approval    Cardiovascular Business

SemaglutideFDAWeight Loss
MONITOR
Mass General Brigham

Weight Loss Drugs and Blindness: Is There a Link?

Weight Loss Drugs and Blindness: Is There a Link?

Weight Loss
MONITOR
NutraIngredients.com

Dietitian explains ‘ideal’ conditions for NAD+ supplementation

Dietitian explains ‘ideal’ conditions for NAD+ supplementation    NutraIngredients.

NAD+
MONITOR
Harvard Gazette

Weight loss drugs protect heart patients, study suggests

Weight loss drugs protect heart patients, study suggests    Harvard Gazette

Weight Loss
MONITOR
Clinical Trials Arena

ESC 2025: study supports use of semaglutide, tirzepatide in cardiometabolic HFpEF patients

ESC 2025: study supports use of semaglutide, tirzepatide in cardiometabolic HFpEF patients    Clinical Trials Arena

SemaglutideTirzepatideClinical Trial
MONITOR
Vogue

Is NAD+ Skin Care the Secret to Aging Backward?

Is NAD+ Skin Care the Secret to Aging Backward?

NAD+
MONITOR
London Evening Standard

Best NAD+ supplements for a natural energy boost

Best NAD+ supplements for a natural energy boost    London Evening Standard

NAD+
MONITOR
iHeartDogs.com

5 Best BPC-157 Peptide Products for Dogs

5 Best BPC-157 Peptide Products for Dogs    iHeartDogs.

BPC-157
MONITOR
Allure

I Got the NAD+ IV Infusion Drip Beloved by Celebs and Finance Bros

I Got the NAD+ IV Infusion Drip Beloved by Celebs and Finance Bros    Allure

NAD+
MONITOR
ELLE

What Is NAD+? Everything to Know About the Celebrity Biohacking Trend

What Is NAD+?

NAD+
MONITOR
The Guardian

‘It’s not ethical and it’s not medical’: how UK rehab clinics are cashing in on NAD+

‘It’s not ethical and it’s not medical’: how UK rehab clinics are cashing in on NAD+    The Guardian

NAD+
MONITOR
American Heart Association Journals

Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study

Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study    American Heart Association Journals

Cerebrolysin
MONITOR
USA Today

Gwyneth Paltrow, online influencers love glutathione. Can it really increase your lifespan?

Gwyneth Paltrow, online influencers love glutathione.

Glutathione
MONITOR
HealthCentral

NAD+ for Skin Health: Can It Help Eczema, Psoriasis, and Aging?

NAD+ for Skin Health: Can It Help Eczema, Psoriasis, and Aging?

NAD+
MONITOR
The Zoe Report

Do Hailey Bieber's Beloved NAD+ IVs Make You Look Younger?

Do Hailey Bieber's Beloved NAD+ IVs Make You Look Younger?

NAD+
MONITOR
Byrdie

A Glutathione Injection Is an Antioxidant Shot that Promises Brighter Skin; Does it Work?

A Glutathione Injection Is an Antioxidant Shot that Promises Brighter Skin; Does it Work?

Glutathione
MONITOR
News-Medical

Glutathione found to significantly reduce acetaldehyde levels and help relieve hangovers

Glutathione found to significantly reduce acetaldehyde levels and help relieve hangovers    News-Medical

Glutathione
MONITOR
Nature

Downregulation of 4-HNE and FOXO4 collaboratively promotes NSCLC cell migration and tumor growth

Downregulation of 4-HNE and FOXO4 collaboratively promotes NSCLC cell migration and tumor growth    Nature

FOXO4
MONITOR
Hone Health

Everything You Need to Know About the FDA Peptide Ban

Everything You Need to Know About the FDA Peptide Ban    Hone Health

FDA
MONITOR
Nature

Deciphering the mechanism of glutaredoxin-catalyzed roGFP2 redox sensing reveals a ternary complex with glutathione for protein disulfide reduction

Deciphering the mechanism of glutaredoxin-catalyzed roGFP2 redox sensing reveals a ternary complex with glutathione for protein disulfide reduction    Nature

Glutathione
MONITOR
Nature

Association of reduced glutathione levels with Plasmodium falciparum and Plasmodium vivax malaria: a systematic review and meta-analysis

Association of reduced glutathione levels with Plasmodium falciparum and Plasmodium vivax malaria: a systematic review and meta-analysis    Nature

Glutathione
MONITOR
Verywell Health

What Is NAD+ And Can It Really 'Reverse' Aging?

What Is NAD+ And Can It Really 'Reverse' Aging?

NAD+
MONITOR
Cureus

The Key Role of Glutathione Compared to Curcumin in the Management of Systemic Lupus Erythematosus: A Systematic Review

The Key Role of Glutathione Compared to Curcumin in the Management of Systemic Lupus Erythematosus: A Systematic Review    Cureus

Glutathione
MONITOR
Nature

Glutathione prevents high glucose-induced pancreatic fibrosis by suppressing pancreatic stellate cell activation via the ROS/TGFβ/SMAD pathway

Glutathione prevents high glucose-induced pancreatic fibrosis by suppressing pancreatic stellate cell activation via the ROS/TGFβ/SMAD pathway    Nature

Glutathione
MONITOR
MyJoyOnline

No injectable glutathione or skin lightening agents have been approved for use – FDA

No injectable glutathione or skin lightening agents have been approved for use – FDA    MyJoyOnline

GlutathioneFDA
MONITOR
Frontiers

A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+

A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+    Frontiers

NAD+
MONITOR
fda.gov

FDA highlights concerns with using dietary ingredient glutathione to c

FDA highlights concerns with using dietary ingredient glutathione to c    fda.

GlutathioneFDA
MONITOR
Cochrane.org

Podcast: Cerebrolysin for acute ischaemic stroke

Podcast: Cerebrolysin for acute ischaemic stroke    Cochrane.

Cerebrolysin
MONITOR
American Heart Association Journals

Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases | Circulation Research

Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases | Circulation Research    American Heart Association Journals

NAD+Research
MONITOR
Nature

MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4

MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4    Nature

FOXO4
MONITOR
Nature

Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione

Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione    Nature

Glutathione
MONITOR
Nature

Ultrasmall Glutathione-Protected Gold Nanoclusters as Next Generation Radiotherapy Sensitizers with High Tumor Uptake and High Renal Clearance

Ultrasmall Glutathione-Protected Gold Nanoclusters as Next Generation Radiotherapy Sensitizers with High Tumor Uptake and High Renal Clearance    Nature

Glutathione
MONITOR
Nature

Glutathione Depletion, Lipid Peroxidation and Mitochondrial Dysfunction Are Induced by Chronic Stress in Rat Brain

Glutathione Depletion, Lipid Peroxidation and Mitochondrial Dysfunction Are Induced by Chronic Stress in Rat Brain    Nature

Glutathione
AUTO-GENERATED FEEDUPDATED HOURLY